Trade Summary

4 days ago, Dunton Alan W, serving as Dir at Cormedix Inc. (CRMD), sold 20,000 shares at $13.00 per share, for a total transaction value of $260,000.00. Following this transaction, Dunton Alan W now holds 40,250 shares of CRMD.

This sale represents a 33.00% decrease in Dunton Alan W's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, December 30, 2025 and publicly disclosed via SEC Form 4 filing on Friday, January 2, 2026, 3 days after the trade was made.

Cormedix Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.